Top Toronto, Ontario Biotech Companies (29)
Don't see your company?
Create a company profile
Founded in 2012, GeneYouIn, the provider of Pillcheck, helps individuals and their healthcare providers choose the right medications to feel better sooner. Many health plans partner with Pillcheck to bring the positive health impacts of precision medicine to their members. Pillcheck was the first platform combining DNA analysis with clinical pharmacy services, and we remain leaders in the field. We operate in North America and Europe, complying with healthcare and data privacy regulations globally. Our multi-lingual software-enabled service integrates expert pharmacist reviews and delivers the consistent application of precision medicine insights for individuals, businesses, and healthcare providers. Pillcheck’s technology architecture addresses the demand for rapid deployment, flexible configuration, and evolving precision medicine programs over time based on data analysis. The Pillcheck platform automates the analysis of genetic data. It includes an auditable gateway for managing genetic and drug-reference information. In addition, the secure front-end web application facilitates role-based access for the provision of reliable DNA-guided prescribing. Clinical diagnostic laboratories in the US, Canada and Europe have independently validated our bioinformatics system. We partner only with certified clinical genetic laboratories
We are scientists, environmentalists and engineers with a belief in better materials. We believe in the power of plants to transform the zero-waste landscape. Single use plastics made with our solutions are compostable, and compatible with existing plastic technology, making plant powered plastics the natural choice. Established as a Canadian green technology company in 2018, we build solutions on a global scale. We're not reinventing the wheel - we're just making it more sustainable.
Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.
Pillcheck is a genomics-guided personalized medication management service that predicts how medications work, limiting potential side effects and helping individuals feel better sooner. Pillcheck’s proprietary Enterprise Platform connects healthcare providers and consumers while reducing exposure to unnecessary costs for payers. Pillcheck works with insurers, corporate benefit plans, and benefits advisors to bring precision medicine to the workplace, following best practices around genetic non-discrimination legislation and health data privacy laws. Our Technology: The Pillcheck platform automates the analysis of genetic data. It includes an auditable gateway for managing genetic and drug-reference information. In addition, the secure front-end web application facilitates role-based access for the provision of reliable DNA-guided prescribing. Clinical diagnostic laboratories in the US, Canada and Europe have independently validated our bioinformatics system. We partner only with certified clinical genetic laboratories.
Pioneering next-gen precision therapeutics for diseases stemming from microtubule dysfunction, such as neuropathies and cardiovascular diseases.
Biossil is an applied AI drug discovery platform founded to develop targeted therapies for biologically defined patient sub-populations. Our focus is on diseases for which traditional drug discovery has been challenged by population variability.
Centricity Research is an integrated research organization (IRO) with more than 40 wholly owned and integrated clinical research offices across North America. The company conducts Phase I-IV clinical research in over 35 therapeutic areas: inpatient and outpatient; pharmaceutical, biotechnology, and medical device trials. For more than 25 years, the organization’s founders have worked to revolutionize research by investing in the people and technology needed to deliver outstanding clinical trial experiences, earning numerous awards including “Best Places to Work” and recognition for “Outstanding Diversity in Clinical Research.” Jobseekers: Apply here >> https://centricityresearch.applytojob.com/apply
Affinity Biologicals, Inc. is a primary manufacturer of products used worldwide in thrombosis and hemostasis research and diagnostics. Our products include an extensive line of antibodies, conjugates, antibody pairs for immunoassay of human and animal analytes, the VisuLize line of complete ELISA kits, and a full line of human plasma products including VisuDep Immune-Depleted Factor-Deficient Plasmas, VisuCal Calibrator Plasma and VisuCon Control Plasmas. Services include protein purification, antibody production, assay development, custom manufacturing including custom lyophilization and proficiency testing materials. For more information please visit www.affinitybiologicals.com.
Vital was created to enable proactive, preventative, and accessible healthcare. We're starting with a radically disruptive approach to lab testing. Backed by many years of R&D by world-class scientists and engineers, we are a team of collaborators, re-engineering the nature of care delivery.
Avicanna is a Canadian international commercial-stage biopharmaceutical company. Focused on the advancement and commercialization of evidence-based cannabinoid-based products for the global medical and pharmaceutical market segments. Avicanna has an established scientific platform including R&D and clinical development that has led to the commercialization of more than thirty products across five market segments: MyMedi.ca Medical Cannabis Care Portal, Medical Cannabis & Wellness Products, Cosmetic & Skincare, Pharmaceutical Pipeline, and Active Pharmaceutical Ingredients (API).
Novel Biotechnology is a Synthetic Biology company focused on developing highly productive pDNA manufacturing platform. We also provide CRDMO and plasmid DNA manufacturing services to our clients
ProteinQure is a revenue-generating software platform for computational protein drug discovery. We combine molecular simulations, machine learning, and quantum computing to do the structure-based design of drugs. These physics-based methods make us less dependent on large data sets and that allows us to explore novel protein structures and interactions. We use our computational platform (as well as wetlab validation) to solve our partners drug design challenges and deliver new therapeutic candidates. We have a very diverse team of multi-disciplinary scientists and engineers. We are based in Toronto, Canada and are funded by top tier venture firms. If you are interested in building the next generation of computational biology tools we hope you will join us.
At Horizon Therapeutics, we believe science and compassion must work together to transform lives. We are driven to deliver innovative medicines to those living with rare, autoimmune and severe inflammatory diseases because we uniquely understand the patient journey. For us, success is measured by the numbers that matter most – the number of lives we touch, the number we change and those we work to help save.
Geneseeq is a research-driven company providing cutting-edge next-generation sequencing (NGS) technology to accelerate precision cancer care. We offer both pan-cancer panels analyzing 400+ genes and cancer-type specific gene panels for all sample types to help match a patient to the optimal treatment, including targeted therapy and immunotherapy. We have 1000+ research projects with biopharma and research partners, providing high-quality genomic data to accelerate translational research. Our headquarters are located in both Canada and China. Our CAP/CLIA accredited clinical laboratory is equipped with multiple advanced NGS sequencing platforms. We work closely with you to solve your specific needs, with a relentless focus on quality and efficiency. Let’s accelerate precision cancer care, together.
BlueRock Therapeutics is a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. BlueRock Therapeutics’ cell+gene platform harnesses the power of cells to create new medicines for neurology, cardiology, and immunology indications. BlueRock Therapeutics’ cell differentiation technology recapitulates the cell’s developmental biology to produce authentic cell therapies, which are further engineered for additional function. Utilizing these cell therapies to replace damaged or degenerated tissue brings the potential to restore or regenerate lost function. BlueRock’s culture is defined by scientific innovation, the highest ethical standards and an urgency to bring transformative treatments to all who would benefit. The company strives to be a top employer of scientific talent, empowering every member of the team to make meaningful and lasting contributions to the burgeoning field of regenerative medicine. Become a BlueRocker! We are expanding our BlueRock team at all locations. Contact us via LinkedIn or our website to learn about rewarding career opportunities.
We are transforming music into medicine. LUCID creates digital therapeutics using cutting-edge Emotion AI to improve health & wellness through the power of music. We're developing accessible and personalized digital therapeutics for a range of health conditions - including Anxiety, Alzheimer's, Paediatric Stress, Burnout, Tinnitus, and more
Phenomic is an innovative biotech company based in Boston and Toronto that specializes in developing new medicines targeting the tumor stroma. The tumor stroma is a dense web of connective tissue that surrounds solid tumors and plays a crucial role in treatment resistance and disease progression. Phenomic's scTx platform contains an extensive and optimally-curated atlas of single-cell cancer and normal tissue data and is powered by proprietary machine learning software to provide unparalleled insight into target expression and selectivity. Using scTx, Phenomic can identify exquisitely selective targets that can directly reprogram the tumor microenvironment or deliver cancer-killing payloads such as immune engagers and antibody-drug conjugates. Additionally, Phenomic has developed tumor stroma-specific experimental systems, including co-culture and disease-relevant in vivo models, to dissect stromal biology and maximize the likelihood of clinical success. Phenomic's lead program targets a novel extracellular matrix protein identified by scTx that is highly tumor selective and expressed by a pathogenic subtype of cancer-associated fibroblasts we term ecmCAFs. We have demonstrated clear in vivo proof-of-concept for this program building our conviction in scTx’s ability to identify novel high-impact, druggable targets.
Nicoya is a Canadian biotechnology company dedicated to improving human life by helping scientists succeed. Established in 2012, Nicoya was founded by Ryan Denomme in his relentless pursuit to use nanotechnology to increase the affordability and ease of use of scientific instruments. Within 10 years, Nicoya has grown to a team of 100+ employees who have extensive experience working at the forefront of nanotechnology and biotechnology sectors. Nicoya develops innovative and accessible biosensor technology for in-depth characterization of biomolecular interactions. Alto, the world’s first digital high-throughput benchtop SPR instrument, is capable of accelerating drug discovery using a fraction of sample volume traditionally required for biomolecular interaction analyses. Alto helps biotechnology and pharmaceutical companies go-to-market faster with increased efficiency and success early in their product pipelines. Join us on our mission to improve human life by helping scientists to succeed. For job opportunities, see our webpage at https://nicoyalife.com/about/careers/
Rapid Novor Inc. is the world's leader in antibody protein sequencing technology. Specializing in the field of mass spectrometry-based proteomics, the team has developed the technology to directly sequence antibody proteins without needing to access the producing cell line. As a University of Waterloo spin-off, the company is building its technology portfolios based on the twenty years of scientific research and inventions from Dr. Bin Ma, co-founder and chief scientist. The company's REmAb™ antibody protein sequencing service has allowed for the accurate sequencing of any given antibody proteins on a routine basis. The company's WILD™ service is the first commercially available service that can accurately distinguish the isobaric Isoleucine and Leucine using mass spectrometry. The company's mission is to advance life science for better human health with next generation protein sequencing. For more information, visit www.rapidnovor.com. Follow the company on Twitter @rapidnovor.
The best anti-aging resource is your own younger cells. Personalized regenerative medicine is the opportunity to leverage strategies that tap into the power of our own cells to treat our bodies. Our cells have the potential to rejuvenate skin, replenish hair, and even help fight disease. Preserving your own cells today can give you access to your own younger cells to use in revolutionary treatments for the rest of your life.
Work Your Passion. Live Your Purpose.
